Oncothyreon Announces Presentation of Positive ONT-380 Data in HER2-Positive Breast Cancer at ASCO Annual Meeting and Updates Development Plan
May 30, 2015 09:00 ET
|
Cascadian Therapeutics, Inc.
SEATTLE, May 30, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today announced the presentation of positive data from the company's ongoing trials of ONT-380, an orally active, reversible...
Oncothyreon to Present at Jefferies 2015 Healthcare Conference
May 26, 2015 08:00 ET
|
Cascadian Therapeutics, Inc.
SEATTLE, May 26, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at the Jefferies 2015...
Oncothyreon Reports First Quarter 2015 Financial Results
May 11, 2015 16:01 ET
|
Cascadian Therapeutics, Inc.
SEATTLE, May 11, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today reported financial results for the first quarter ended March 31, 2015.
Net loss for the three months ended March 31,...
Oncothyreon Announces First Quarter 2015 Financial Results Conference Call
May 04, 2015 08:00 ET
|
Cascadian Therapeutics, Inc.
SEATTLE, May 4, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today announced that it will conduct a conference call on Monday, May 11, 2015 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to...
Oncothyreon Reports Full Year and Fourth Quarter 2014 Financial Results
March 10, 2015 16:01 ET
|
Cascadian Therapeutics, Inc.
SEATTLE, March 10, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today reported financial results for the year and quarter ended December 31, 2014.
Net loss for the year ended December 31,...
Oncothyreon Announces Appointment of Steven P. James to Board of Directors
March 03, 2015 08:01 ET
|
Cascadian Therapeutics, Inc.
SEATTLE, March 3, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today announced the appointment of Steven P. James to its board of directors.
"We are pleased to welcome Steve, with his...
Oncothyreon Announces Full Year and Fourth Quarter 2014 Financial Results Conference Call
March 03, 2015 08:00 ET
|
Cascadian Therapeutics, Inc.
SEATTLE, March 3, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today announced that it will conduct a conference call on Tuesday, March 10, 2015 at 4:30 p.m. Eastern Time (1:30 p.m....
Oncothyreon to Present at Upcoming Investor Conferences
February 17, 2015 08:00 ET
|
Cascadian Therapeutics, Inc.
SEATTLE, Feb. 17, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at two upcoming...
Oncothyreon Prices $22 Million Concurrent Public Offerings of Common Stock and Preferred Stock
February 06, 2015 08:49 ET
|
Cascadian Therapeutics, Inc.
SEATTLE, Feb. 6, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today announced the pricing of previously announced concurrent but separate underwritten offerings of 13,500,000 shares of...
Oncothyreon Announces Proposed Public Offerings
February 05, 2015 16:01 ET
|
Cascadian Therapeutics, Inc.
SEATTLE, Feb. 5, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today announced that it intends to offer and sell shares of its Common Stock and Series B Convertible Preferred Stock in...